tert-Butyl 4-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate

Catalog No. :
ACOYGP540
CAS No. :
1782622-45-0
Molecular Formula :
C13H21NO4
Molecular Weight :
255.31

IUPAC Name:tert-butyl 4-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate

tert-Butyl 4-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$65.00Login to see priceIn stockInquiry
250mg95%$107.00Login to see priceIn stockInquiry
1g95%$213.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate
IUPAC Nametert-butyl 4-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate
MDL No.MFCD26710389
Molecular FormulaC13H21NO4
Molecular Weight255.31
SMILESO=C(N(CC1)CCC1(OCC2)C2=O)OC(C)(C)C
InChI KeyDXERLBFKDLTNKK-UHFFFAOYSA-N
SynonymTert-Butyl 4-Oxo-1-Oxa-8-Azaspiro[4.5]Decane-8-Carboxylate;Tert-Butyl 4-Oxo-1-Oxa-8-Azaspiro[4.5]Decane-8-Carboxylate(WX101840);1-Oxa-8-azaspiro[4.5]decane-8-carboxylic acid, 4-oxo-, 1,1-dimethylethyl ester;8-Boc-4-oxo-1-oxa-8-azaspiro[4.5]decane;tert-butyl 4-oxo-1-Oxa-8-azaspiro[4.5]decane-8-carboxylate - [B83716]
CAS No.1782622-45-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOYGP540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOYGP540 route product structure diagram
    ACOYGP5401782622-45-0 In Stock
Inquiry

2. ACOYGP540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOYGP540 route product structure diagram
    ACOYGP5401782622-45-0 In Stock
Inquiry

Comments (0)